{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:47Z","timestamp":1707524387214},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,6]]},"DOI":"10.7759\/cureus.17766","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:37:00Z","timestamp":1630953420000},"source":"Crossref","is-referenced-by-count":0,"title":["A Perplexing Case of Recurrent Abscess-Like Lesions: Insights Into Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"],"prefix":"10.7759","author":[{"given":"Syed Hamza","family":"Bin Waqar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unaiza","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Salahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raavi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel M","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze R","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019, 133:1703-14. 10.1182\/blood-2018-11-881268","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00651","article-title":"Primary cutaneous B-cell lymphomas: an update","volume":"10","author":"Vitiello P","year":"2020","unstructured":"Vitiello P, Sica A, Ronchi A, Caccavale S, Franco R, Argenziano G. Primary cutaneous B-cell lymphomas: an update. Front Oncol. 2020, 10:651. 10.3389\/fonc.2020.00651","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze R","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, et al.. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005, 105:3768-85. 10.1182\/blood-2004-09-3502","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.2018.014","article-title":"Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Chen ST","year":"2018","unstructured":"Chen ST, Barnes J, Duncan L. Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018, 37:49-55. 10.12788\/j.sder.2018.014","journal-title":"Semin Cutan Med Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff NJ","year":"2009","unstructured":"Senff NJ, Zoutman WH, Vermeer MH, et al.. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol. 2009, 129:1149-55. 10.1038\/jid.2008.357","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard A","year":"2014","unstructured":"Pham-Ledard A, Prochazkova-Carlotti M, Andrique L, et al.. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma. Mod Pathol. 2014, 27:402-11. 10.1038\/modpathol.2013.156","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.265","article-title":"Nuclear factor-\u03baB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type","volume":"134","author":"Koens L","year":"2014","unstructured":"Koens L, Zoutman WH, Ngarmlertsirichai P, et al.. Nuclear factor-\u03baB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type. J Invest Dermatol. 2014, 134:290-2. 10.1038\/jid.2013.265","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/107327481201900308","article-title":"Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management","volume":"19","author":"Sokol L","year":"2012","unstructured":"Sokol L, Naghashpour M, Glass LF. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Cancer Control. 2012, 19:236-44. 10.1177\/107327481201900308","journal-title":"Cancer Control"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff NJ","year":"2008","unstructured":"Senff NJ, Noordijk EM, Kim YH, et al.. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008, 112:1600-9. 10.1182\/blood-2008-04-152850","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2015.6067","article-title":"Excellent outcome of immunomodulation or Bruton's tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"7","author":"Gupta E","year":"2015","unstructured":"Gupta E, Accurso J, Sluzevich J, Menke DM, Tun HW. Excellent outcome of immunomodulation or Bruton's tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Rare Tumors. 2015, 7:6067. 10.4081\/rt.2015.6067","journal-title":"Rare Tumors"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.03.1516","article-title":"A single-arm phase II trial of lenalidomide in relapsing or refractory primary cutaneous large b-cell lymphoma, leg type","volume":"138","author":"Beylot-Barry M","year":"2018","unstructured":"Beylot-Barry M, Mermin D, Maillard A, et al.. A single-arm phase II trial of lenalidomide in relapsing or refractory primary cutaneous large b-cell lymphoma, leg type. J Invest Dermatol. 2018, 138:1982-9. 10.1016\/j.jid.2018.03.1516","journal-title":"J Invest Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/70068-a-perplexing-case-of-recurrent-abscess-like-lesions-insights-into-primary-cutaneous-diffuse-large-b-cell-lymphoma-leg-type","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:24Z","timestamp":1707506964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/70068-a-perplexing-case-of-recurrent-abscess-like-lesions-insights-into-primary-cutaneous-diffuse-large-b-cell-lymphoma-leg-type"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.17766","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,6]]}}}